Is Ubrelvy known to constrict blood vessels?
Note: The statement is on the mechanism of action page of the Ubrelvy HCP site, under a heading comparing UBRELVY with triptans, and cites the American Headache Society position statement on integrating new migraine treatments into clinical practice (Headache 2019). The Prescribing Information makes no statement about vasoconstriction; it lists hypertension and Raynaud's phenomenon, reported after use of CGRP antagonists including UBRELVY, under Warnings and Precautions.